[Retracted] TJZYF Improves Endometrial Receptivity through Regulating VEGF and PI3K/AKT Signaling Pathway

Figure 3

Molecular docking analysis between two key components of TJZYF and AKT1, VEGFA. (a) Docking studies of human AKT1 with quercetin and (b) stigmasterol. (c) Docking studies of human VEGFA with quercetin and (d) stigmasterol. The protein structures of AKT1 and VEGFA are shown as cyan and rosy cartoon, respectively. The green color indicates molecules. The residues involved in hydrogen bonding interaction (yellow dash lines) have been shown in sticks.

(a)

(b)

(c)

(d)